CasImg
红陪酚
产品纠错
CAS号:569-77-7 | 英文名称:PURPUROGALLIN
分子式 C11H8O5
分子量 220
EINECS号 209-324-9
MDL MFCD00004145
Smiles C12=C(O)C(O)=C(O)C=C1C=CC=C(O)C2=O
InChIKey WDGFFVCWBZVLCE-UHFFFAOYSA-N
乙二醇化学百科
基本信息
中文名称 红陪酚
英文名称 PURPUROGALLIN
CAS号 569-77-7
分子式 C11H8O5
分子量 220.18
EINECS号 209-324-9
物化性质
熔点 275 °C (dec.)(lit.)
沸点 321.11°C (rough estimate)
密度 1.3824 (rough estimate)
折射率 1.5140 (estimate)
LogP 2.050 (est)
溶解度 可溶于DMSO(少许)、甲醇(少许)
形态 固体
酸度系数(pKa) 6.75±0.20(Predicted)
颜色 深棕色低熔点
Merck 7946
稳定性 空气敏感
安全信息
危险品标志 Xi
危险类别码 36/37/38
安全说明 26-36
WGK Germany 3
RTECS号 DE8380000
生产及用途
Purpurogallin 是从栎属植物中提取的天然酚,具有强的黄嘌呤氧化酶 (Xanthine Oxidase) 抑制活性,其 IC50 为 0.2 µM。Purpurogallin 具有抗氧化和抗炎作用。

IC50: 0.2 µM (xanthine oxidase)

Purpurogallin (50 or 100 µM; 7 or 25 hours; BV2 murine microglial cells) treatment attenuates the production of pro-inflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) by suppressing their mRNA and protein expression in LPS-stimulated BV2 microglial cells.
Purpurogallin (100 µM; 75-120 minutes; BV2 murine microglial cells) exhibits anti-inflammatory properties by suppressing the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase signaling pathways in LPS-stimulated BV2 microglial cells.

RT-PCR

Cell Line: BV2 murine microglial cells
Concentration: 50 or 100 µM
Incubation Time: 7 or 25 hours
Result: Attenuated the production of pro-inflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) by suppressing their mRNA and protein expression.

Western Blot Analysis

Cell Line: BV2 murine microglial cells
Concentration: 100 µM
Incubation Time: 75 minutes, 90 minutes, 120 minutes
Result: Suppressed the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase signaling pathways.

Purpurogallin (100-400 μg/kg; intraperitoneal injection; for 48 or 72 hours; male Sprague-Dawley rats) exerts its neuroinflammation effect through the dual effect of inhibiting IL-6 and TNF-α mRNA expression and reducing HMGB1 protein and mRNA expression.

Animal Model: Fifty-four male Sprague-Dawley rats (250-350 g) with subarachnoid hemorrhage (SAH)
Dosage: 100 μg/kg, 200 μg/kg, 400 μg/kg
Administration: Intraperitoneal injection; for 48 or 72 hours
Result: Dose-dependently reduced HMGB1 protein expression. High dose reduced TNF-α and HMGB1 mRNA levels.
上下游产品
上游产品共计:0个
下游产品共计:0个
产品供应商

首页 |  CAS目录 |  产品目录 |  企业会员 |  关于我们 |  法律声明 |  注册协议

Copyright © 冀ICP备2024096099号